World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
67
Citations
14578
World Ranking
2289
National Ranking
940

Medicine

D-Index
74
Citations
17612
World Ranking
19473
National Ranking
9694

Overview

Eric L. Nuermberger is affiliated with Johns Hopkins University in the United States. Their research focuses primarily on Medicine, with notable contributions in Biochemistry, Genetics and Molecular Biology. Within these broad fields, their work has significant emphasis on Infectious Diseases, Epidemiology, Molecular Biology, Surgery, and Molecular Medicine.

The main topics of Eric L. Nuermberger's work include Tuberculosis Research and Epidemiology, Mycobacterium research and diagnosis, Cancer therapeutics and mechanisms, Pneumocystis jirovecii pneumonia detection and treatment, Antibiotic Resistance in Bacteria, Infectious Diseases and Tuberculosis, and Antibiotics Pharmacokinetics and Efficacy.

They have published extensively in a range of scientific journals. The most frequent publication venues are:

  • Antimicrobial Agents and Chemotherapy
  • bioRxiv (Cold Spring Harbor Laboratory)
  • American Journal of Respiratory and Critical Care Medicine
  • Nature Communications
  • ACS Infectious Diseases

Eric L. Nuermberger has collaborated with several co-authors, notable among them are:

  • Paul J. Converse
  • Rokeya Tasneen
  • Nader Fotouhi
  • Si-Yang Li
  • Deepak V. Almeida

Recent publications by Eric L. Nuermberger include:

  • Mutations in fbiD (Rv2983) as a Novel Determinant of Resistance to Pretomanid and Delamanid in Mycobacterium tuberculosis, 2020, Antimicrobial Agents and Chemotherapy
  • Predicting nitroimidazole antibiotic resistance mutations in Mycobacterium tuberculosis with protein engineering, 2020, PLoS Pathogens
  • Genome-Wide Essentiality Analysis of Mycobacterium abscessus by Saturated Transposon Mutagenesis and Deep Sequencing, 2021, mBio
  • Short oral regimens for pulmonary rifampicin-resistant tuberculosis (TB-PRACTECAL): an open-label, randomised, controlled, phase 2B-3, multi-arm, multicentre, non-inferiority trial, 2023, The Lancet Respiratory Medicine
  • Comparative Efficacy of the Novel Diarylquinoline TBAJ-587 and Bedaquiline against a Resistant Rv0678 Mutant in a Mouse Model of Tuberculosis, 2021, Antimicrobial Agents and Chemotherapy

Best Publications

  • Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat.

    Nicola Zetola;John S Francis;Eric L Nuermberger;William R Bishai

  • Severe Community-Onset Pneumonia in Healthy Adults Caused by Methicillin-Resistant Staphylococcus aureus Carrying the Panton-Valentine Leukocidin Genes

    John S. Francis;Meg C. Doherty;Uri Lopatin;Cecilia P. Johnston

  • The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis

    Keertan Dheda;Tawanda Gumbo;Gary Maartens;Kelly E. Dooley

  • Moxifloxacin-containing Regimen Greatly Reduces Time to Culture Conversion in Murine Tuberculosis

    Eric L. Nuermberger;Tetsuyuki Yoshimatsu;Sandeep Tyagi;Richard J. O'Brien

  • Substitution of Moxifloxacin for Isoniazid during Intensive Phase Treatment of Pulmonary Tuberculosis

    Susan E. Dorman;John L. Johnson;Stefan Goldberg;Grace Muzanye

  • Targeting DnaN for tuberculosis therapy using novel griselimycins

    Angela Kling;Peer Lukat;Deepak V. Almeida;Armin Bauer

  • Dormancy Phenotype Displayed by Extracellular Mycobacterium tuberculosis within Artificial Granulomas in Mice

    Petros C. Karakousis;Tetsuyuki Yoshimatsu;Gyanu Lamichhane;Samuel C. Woolwine

  • Mouse Model of Necrotic Tuberculosis Granulomas Develops Hypoxic Lesions

    Jamie Harper;Ciaran Skerry;Stephanie L. Davis;Rokeya Tasneen

  • Bactericidal Activity of the Nitroimidazopyran PA-824 in a Murine Model of Tuberculosis

    Sandeep Tyagi;E. Nuermberger;T. Yoshimatsu;K. Williams

  • Promising Clinical Efficacy of Streptomycin-Rifampin Combination for Treatment of Buruli Ulcer (Mycobacterium ulcerans Disease)

    Annick Chauty;Marie Françoise Ardant;Ambroise Adeye;Hélène Euverte

  • Moxifloxacin-containing Regimens of Reduced Duration Produce a Stable Cure in Murine Tuberculosis

    Eric L. Nuermberger;Tetsuyuki Yoshimatsu;Sandeep Tyagi;Kathy Williams

  • Comprehensive analysis of methods used for the evaluation of compounds against Mycobacterium tuberculosis

    Scott G. Franzblau;Mary Ann DeGroote;Sang Hyun Cho;Koen Andries

  • Daily Dosing of Rifapentine Cures Tuberculosis in Three Months or Less in the Murine Model

    Ian M Rosenthal;Ming Zhang;Kathy N Williams;Charles A Peloquin

  • Promising Antituberculosis Activity of the Oxazolidinone PNU-100480 Relative to That of Linezolid in a Murine Model

    K. N. Williams;C. K. Stover;T. Zhu;R. Tasneen

  • Powerful Bactericidal and Sterilizing Activity of a Regimen Containing PA-824, Moxifloxacin, and Pyrazinamide in a Murine Model of Tuberculosis

    Eric Nuermberger;Sandeep Tyagi;Rokeya Tasneen;Kathy N. Williams

  • Sterilizing Activity of Novel TMC207- and PA-824-Containing Regimens in a Murine Model of Tuberculosis

    Rokeya Tasneen;Si Yang Li;Charles A. Peloquin;Dinesh Taylor

  • Mutations in pepQ Confer Low-Level Resistance to Bedaquiline and Clofazimine in Mycobacterium tuberculosis

    Deepak Almeida;Thomas Ioerger;Sandeep Tyagi;Si Yang Li

  • Presence of multiple lesion types with vastly different microenvironments in C3HeB/FeJ mice following aerosol infection with Mycobacterium tuberculosis.

    Scott M. Irwin;Emily Driver;Edward Lyon;Christopher Schrupp

  • Sterilizing Activities of Novel Combinations Lacking First- and Second-Line Drugs in a Murine Model of Tuberculosis

    Kathy Williams;Austin Minkowski;Opokua Amoabeng;Charles A. Peloquin

  • Role of the dosR-dosS Two-Component Regulatory System in Mycobacterium tuberculosis Virulence in Three Animal Models†

    Paul J. Converse;Petros C. Karakousis;Lee G. Klinkenberg;Anup K. Kesavan

Frequent Co-Authors

Jacques H. Grosset
Jacques H. Grosset Johns Hopkins University School of Medicine
William R. Bishai
William R. Bishai Johns Hopkins University
Petros C. Karakousis
Petros C. Karakousis Johns Hopkins University
Tawanda Gumbo
Tawanda Gumbo Baylor University Medical Center
Richard E. Chaisson
Richard E. Chaisson Johns Hopkins University
Véronique Dartois
Véronique Dartois Rutgers, The State University of New Jersey
James C. Sacchettini
James C. Sacchettini Texas A&M University
Soumya Swaminathan
Soumya Swaminathan M S Swaminathan Research Foundation
Thomas R. Ioerger
Thomas R. Ioerger Texas A&M University
Barry N. Kreiswirth
Barry N. Kreiswirth Center for Discovery and Innovation

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to various interdisciplinary careers, especially in healthcare and information management. For those interested in the administrative and coding side of healthcare, pursuing a certified professional coder (cpc) credential can be a rewarding path. This certification ensures expertise in medical coding, a vital aspect of healthcare documentation.

Another promising role is that of a health information manager. Entry-level opportunities often require strong knowledge of healthcare data systems and compliance. Understanding the health information management salary entry-level can help prospective students evaluate their career potential early on.

To prepare for these paths, consider accredited programs such as those listed under online health information management degree programs cahiim accredited. These programs ensure quality education that meets industry standards for health information professionals.

For individuals looking to start quickly, an accelerated medical billing and coding certificate online offers a streamlined pathway into the field. These certificates provide essential skills and credentials in less time, making them ideal for those eager to enter the workforce.

Best Scientists Citing Eric L. Nuermberger

Trending Scientists

Recently Published Articles